Business & Regulation

Maeve Magner explains how digital solutions can improve the supply chains of emerging economies.

Should pharma companies transition from developing, manufacturing and pricing “drugs” to promoting “health”?

GDUFA fees for 2020 have been decided – and include a significant drop in the fees for finished dosage facilities.

As US prices for Rx drugs continues to rise, patients are finding themselves priced out of access to much-needed medicines.

Digitalization means a more productive and adaptive plant through the application of analytics to leverage connectivity and data.

SPaeDD, a collaborative effort between industry, academia and contractors, is helping to accelerate pediatric drug development in the UK..

When art and science meet, true inspiration can be found and tapped into.

Is blockchain truly the solution the industry's been looking for?

In times of political and social upheaval, maintaining our links across borders and working closely together is more important than ever.

With a no-deal Brexit still a real possibility, Merck continues to prepare for the worst case scenario.